Back
Aligos Therapeutics 10K Form
Buy
67
ALGS
Aligos Therapeutics
Last Price:
19.46
Seasonality Move:
0%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALGS News And Ratings
See the #1 stock for the next 7 days that we like better than ALGS
ALGS Financial Statistics
Sales & Book Value
| Annual Sales: | $15.53M |
|---|---|
| Cash Flow: | $-20.13M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $15.07 |
| Price / Book: | 1.39 |
Profitability
| EPS (TTM): | -17.10530 |
|---|---|
| Net Income (TTM): | $-76.95M |
| Gross Margin: | -- |
| Return on Equity: | -118.75% |
| Return on Assets: | -68.4% |
Aligos Therapeutics Earnings Forecast
Key Aligos Therapeutics Financial Ratios
- The Research & Development expenses have been 470.35% of Revenue.
- The Net Earning history of ALGS is -564.61% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 3 years.
Aligos Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALGS |
| Website: | aligos.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.81 |
| Quick Ratio: | 3.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ALGS Technical Analysis vs Fundamental Analysis
Buy
67
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a Buy
The current Aligos Therapeutics [ALGS] share price is $19.46. The Score for ALGS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.